Related Experiment Video
Updated: May 29, 2026
11:02
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
Metabolomics as a tool for cardiac research
Julian L Griffin1, Helen Atherton, John Shockcor
1MRC Human Nutrition Research, Elsie Widdowson Laboratory, Fulbourn Road, Cambridge CB1 9NL, UK. jules.griffin@ mrc-hnr.cam.ac.uk
Nature Reviews. Cardiology
|September 21, 2011
Summary
Metabolomics offers a comprehensive view of metabolic networks for disease biomarker discovery. This approach provides mechanistic insights into cardiac diseases like heart failure and aids in tracking drug efficacy.
Area of Science:
- Metabolomics
- Systems Biology
- Biomarker Discovery
Background:
- Traditional metabolic research focused on limited pathways.
- Metabolomics enables high-throughput analysis of complex metabolic networks.
- It is crucial for identifying disease biomarkers and assessing drug efficacy.
Purpose of the Study:
- To review the role of metabolomics in understanding cardiac disease.
- To explore metabolomics for novel cardiac disease biomarker identification.
- To position metabolomics within functional-genomics approaches.
Main Methods:
- High-resolution Nuclear Magnetic Resonance (NMR) spectroscopy.
- Mass spectrometry for metabolite profiling.
- Stable-isotope labeling methods for metabolic flux analysis.
Main Results:
- NMR and mass spectrometry effectively discriminate cardiac pathologies (ischemia, infarction, heart failure).
- Metabolomics complements transcriptomic and proteomic studies.
- Lipidomics is a key subdivision for studying intact lipid species.
Conclusions:
- Metabolomics provides deep mechanistic insights into cardiac disease progression.
- It is a powerful tool for discovering novel cardiac biomarkers.
- Integrating metabolomics with other functional-genomics approaches enhances understanding of cardiac metabolism.
